LastShadow's Position Trading Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : LastShadow's Position Trading

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom pope who wrote (6381)	1/14/1999 12:02:00 PM
From: Vic	Read Replies (3) of 43080

Here's one that's a real sleeper: POSS (Possis Medical) No analyst following yet that I am aware of. The following press release came out today. biz.yahoo.com I'm hearing that FDA approval should be just a month or two away. Management appears to be very conservative. Maybe that's why we don't hear very much about it. Once the price rises above $10 I would expect to see some analyst coverage. I've talked to the company and I think they should have steady earnings growth because of expansion of their sales force and increased interest in their products. Of course, once the AngioJet gets FDA approval who knows what the upside might be. Anybody remember AVEI? Furthermore, there's high short interest in the stock which could cause I nice pop in the price.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next